Objectives: Our objective was to determine the relationship between functional outcome and abnormalities of heart rate and rhythm after the Fontan operation.
Results: Various Fontan procedures had been performed: intracardiac lateral tunnel (59%), atriopulmonary connection (14%), extracardiac later tunnel (13%), and extracardiac conduit (11%). Prior volume unloading surgery was performed in 389 patients: bidirectional Glenn (70%) and hemi-Fontan (26%). A history of atrial tachycardia was noted in 9.6% of patients and 13.1% of patients had a pacemaker. Lower resting heart rate and higher peak heart rate were each weakly associated with better functional status, as defined by higher anaerobic threshold (R 5 20.18, P 5 .004, and R 5 0.16, P 5 .007, respectively) and higher Child Health scores for physical functioning (R 5 20.18, P , .001, and R 5 0.17, P 5 .002, respectively). Higher anaerobic threshold was also independently associated with younger age and an abnormal P-axis. Resting bradycardia was not associated with anaerobic threshold or Child Health scores.
Conclusions:
In pediatric patients (6-18 years) after the Fontan procedure, a lower resting heart rate and a higher peak heart rate are each independently associated with better physical function as measured by anaerobic threshold and Child Health scores. However, these correlations are weak, suggesting that other, nonrhythm and nonrate, factors may have a greater impact on the functional outcome of pediatric patients after the Fontan operation.
H eart rate and rhythm disorders, such as sinus node dysfunction and atrial tachycardia, are common and potentially important late morbidities of the Fontan operation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The incidence of late sinus node dysfunction after the Fontan operation has been reported to be about 15% 1-3 but may occur in up to 44% of patients in selected series. 4 The incidence of atrial tachycardia is 16% to 17% at approximately 5 years after the Fontan procedure 1, 5 and reaches 50% by 12 years. 1 Further, sinus node dysfunction and atrial tachycardia can result in significant symptoms and comorbidities necessitating interventions, including medication, 11 pacing, 12 catheter ablation, 13 and surgery, 14 and may also be associated with an increased risk for late death. 7, 12, 15, 16 However, little is known about the impact of heart rate and rhythm disorders on the daily lives of pediatric patients who have undergone the Fontan operation.
The goal of this study was to analyze heart rate and rhythm data from a large group of Fontan patients studied with a uniform protocol to define the incidence of heart rate Supplemental material is available online. 
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Methods
Fontan Cross-Sectional Study
This report is based on data from the Fontan Cross-Sectional Study executed by the Pediatric Heart Disease Clinical Research Network of the National Heart, Lung, and Blood Institute. The primary aim of this main study was to assess the correlation between functional health status and measures of ventricular performance in children aged 6 to 18 years who have undergone a Fontan procedure. Details regarding the structure of the Pediatric Heart Network and the general methods of the Fontan Cross-Sectional Study have been reported previously. 17 Informed consent was obtained and data were collected at each of the participating centers according to the rules of each institution's internal review board. Heart rate, heart rhythm, and functional analysis-Patient sample. A total of 546 subjects were enrolled in the Fontan Cross-Sectional Study. Twenty-five patients were excluded from this analysis of heart rate and rhythm: In 17, neither an electrocardiogram (ECG) nor an exercise test was available; 7 had undergone surgical conversion of the Fontan circuit, which may have had an impact on arrhythmia development 14 ; and 1 had seconddegree atrioventricular block, leaving 521 subjects in the analytic data set.
Some additional exclusions were applied for selected heart rate and rhythm analyses. Patients with a pacemaker may have had a falsely elevated heart rate at rest and during exercise, whereas patients receivinging antiarrhythmic drugs may have had a falsely lowered heart rate. Thus the physiologic relationship between underlying heart rate and outcome in these patients might not be accurately identified. To avoid this possibility, we excluded from all heart rate analyses 34 subjects with a rate-responsive pacemaker (n 5 5) and/or subjects who were currently treated with betablockers or class III antiarrhythmics (n 5 30), and we excluded 43 subjects with a paced rhythm on resting ECG from the resting heart rate analysis.
Functional outcome measures. The Child Health Questionnaire (CHQ) Parent Report (CHQ-PF50) and the oxygen consumption (volume O 2 $ kg 21 $ min 21 ) at the anaerobic threshold (VAT) during exercise testing were used as measures of functional outcome. The CHQ-PF50 provides physical (CHQ-p) and psychosocial (CHQ-ps) summary scores to describe the well-being of children 5 to 18 years of age. 18 This instrument has been used extensively to establish functional outcome in normal children as well as pediatric patients with various diseases and is among the most reliable tools for this purpose. 19 For this study, VAT was used as the marker for exercise performance because it is less effort dependent than other measures and reflects performance at lower levels of exercise.
ECG. A standard 12-lead ECG was performed in the supine position and recorded at 25-mm/s sweep speed with a 10 mm/ mV-amplitude. All ECGs were performed at supine rest and before any exercise testing. Bradycardia was defined as a resting heart rate less than the fifth percentile for age. 20 Exercise testing. A 12-lead ECG was continuously monitored during the exercise protocol. Arterial oxygen saturation was measured transcutaneously at rest and continuously during exercise. Maximal exercise testing was performed with a standard ramp protocol on an electronically braked cycle ergometer. 21 Oxygen consumption and carbon dioxide production were measured continuously. VAT was measured by the V-slope method in those children in whom it could be accurately determined.
Peak heart rate percent predicted of normal for age was calculated as (peak heart rate/[220 2 age]) 3 100. Chronotropic index 22 was calculated as (peak heart rate 2 resting heart rate)/(0.925 3 [220 2 age 2 resting heart rate]).
Statistical Analysis
Groups were defined by resting heart rate less than fifth percentile, peak heart rate less than 75% of predicted for age, history versus no history of atrial tachycardia, and current versus no pacemaker use. A Fisher exact test was used when comparing the distributions of a categorical variable by group and the Wilcoxon rank sum test was used for comparison of the distribution of most continuous variables. The Student t test was used to compare the distributions of resting heart rate. The Pearson rank correlation coefficient was used to estimate the association between pairs of continuous measures. Multivariate linear regression was used to identify independent predictors of functional outcome, defined as VAT and CHQ-p (physical) summary score.
Results
Enrollment, Demographics, and History
Of the 521 subjects in the analytic cohort, 509 had a supine ECG, 404 completed a bicycle exercise test with VAT measured in 311, and 489 had analyzable CHQ-p summary scores. Table 1 displays patient demographics. The mean age at enrollment was 11.9 6 3.4 years (median 11.3) and at the Fontan procedure was 3.4 6 1.9 years (median 2.8). There were more male (61%) than female patients. Of 389 patients who had undergone a staged second procedure, many more (70%) underwent the bidirectional Glenn than the hemi-Fontan. The intracardiac lateral tunnel was the most frequent form of Fontan procedure seen in these patients (59%), with the 3 other major forms being equally distributed among the remainder of the patients. Sixty-eight (13%) patients had a pacemaker at the time of the study. Fifty (10%) patients had a history of atrial tachycardia, defined as atrial tachycardia noted in the medical record or present on the study ECG or exercise test.
Heart Rate and Rhythm
Resting rhythm. Sinus rhythm was the predominant rhythm on the resting supine ECG in only 69% of patients ( Figure 1 ). Among 470 patients with a P wave on the ECG, 20% had a low right atrial rhythm and 5% had a left atrial focus. Although 13% of patients had a pacemaker, during the resting supine ECG, only 63% of these were paced in the following modes: AAI(R) (69%), DDD(R) (28%), or DDIR (3%).
Resting heart rate. After appropriate exclusions (see Methods), the average resting heart rate on ECG was 76 6 16 beats/min. Resting heart rate decreased slightly with age (R 5 20.15, 95% confidence interval 20.24 to 20.06; P 5 .001). Over one quarter (27%) of patients had a resting heart rate below the fifth percentile for age, but only 0.7% had resting heart rates above the 95th percentile for age. Patients with resting heart rates less than the fifth percentile for age were less likely to be in sinus rhythm and more likely to be in junctional escape rhythm than those patients with resting heart rates greater than the fifth percentile for age (67% vs 79% in normal sinus rhythm and 16% vs 3% in junctional rhythm, respectively; P , .0001).
Peak heart rate. The average peak heart rate during exercise testing in 371 patients was 157 6 21 beats/min and was not associated with age (R 5 0.07, 95% confidence interval 20.04 to 0.17; P 5 .211). Low peak heart rate, defined as less than 75% of predicted for age, was observed in 41% of patients. Mean change in heart rate (peak minus resting) was 83 6 26 beats/min, and the mean chronotropic index (n 5 340) was 0.67 6 0.19 (median 0.70), with 73% having an abnormally low chronotropic index less than 0.8.
Multiple heart rate and rhythm abnormalities. Many subjects had multiple heart rate and rhythm abnormalities. Nine percent had a resting heart rate below the fifth percentile for age and nonsinus rhythm on resting ECG, and 10.9% had a resting heart rate below the fifth percentile for age plus a peak heart rate below 75% of predicted. However, 61% of the 96 patients who had a resting heart rate below the fifth percentile for age had a peak heart rate 75% of predicted or greater.
Functional Outcomes
Mean CHQ-p and CHQ-ps for the group were lower than those for historical healthy controls: CHQ-p was 45.4 6 11.8 (median 49.3) versus 53.0 6 8.8 for historical controls and CHQ-ps was 47.3 6 10.9 (median 48.9) versus 51.2 6 9.1 for historical controls. 18, 19 Mean VAT was low at 18.8 6 6.4 mL $ kg 21 $ min 21 .
Associations with Oxygen Consumption at the Anaerobic Threshold (VAT) VAT was measured in 311 subjects. Higher VAT was weakly associated with lower resting heart rate (R 5 20.18, 95% confidence interval 20.27 to 20.09; P 5 .004; Figure 2 , A) and higher peak heart rate (R 5 0.16, 95% confidence interval 0.04 to 0.27; P 5 .07; Figure 3 , A). When the association between continuous predicted peak heart rate and VAT was examined, the strength and significance of the association was similar to the association between raw peak heart rate and VAT. VAT was not associated with bradycardia (resting heart rate below the fifth percentile for age) or the presence of an atrial pacemaker ( Table 2) . Although patients with an abnormal P-axis had a higher VAT than those with a normal axis (20.7 6 6.8 vs 18.4 6 6.2 mL $ kg 21 $ min 21 ; P 5 .02), VAT did not differ by predominant rhythm, including junctional rhythm, on resting ECG. VAT did not differ by history of atrial tachycardia status or by the use of antiarrhythmic medication. A multivariate model for VAT (n 5 251) using age, rate, and rhythm variables demonstrated that younger age (0.77 mL $ kg 21 $ min 21 increase per 1-year decrease in age; P , .001), lower resting heart rate (0.91 mL $ kg 21 $ min 21 increase per 10 beats/min decrease at rest; P , .001), higher peak heart rate (0.44 mL $ kg 21 $ min 21 increase per 10 beats/min increase during exercise; P 5 .03), and an abnormal P-axis (2.59 mL $ kg 21 $ min 21 decrease if P-axis is between 0 and 90 degrees; P 5 .004) were independent predictors of better performance and accounted for 20% of the variation in VAT. Furthermore, the association between age and resting and peak heart rate was observed at all ages, without a difference between age groups (interaction P values .77 and 0.41, respectively).
Associations with CHQ-p Score
Patients with lower resting heart rates had higher CHQ-p scores, reflecting better functional outcome (R 5 20.18, 95% confidence interval 20.27 to 0.09; P , .001; Figure 2 , B). However, bradycardia was not specifically related to CHQ-p, since mean CHQ-p was similar for patients with a resting heart rate at or above versus below the fifth percentile for age ( Table 2 ). Patients with a higher peak heart rate had higher CHQ-p scores (R 5 0.17, 95% confidence interval 0.06 to 0.27; P 5 .002; Figure 3, B) . When the association between continuous predicted peak heart rate and CHQ-p score was examined, the strength and significance of the association was similar to the association between raw peak heart rate and CHQ-p score. Greater changes in heart rate (peak heart rate minus resting heart rate) were associated with higher CHQ-p scores (R 5 0.19, 95% confidence interval 0.08 to 0.29; P , .001). The presence of an atrial pacemaker was associated with a lower mean CHQ-p score, as was a positive history of atrial tachycardia ( Table 2) . Patients who were treated with beta-blockers or class III antiarrhythmic agents had lower CHQ-p scores than those who were not treated with these medications (38.3 6 15.9 vs 45.9 6 11.3; P 5 .005). Other than having a paced rhythm on resting ECG, predominant rhythm, including junctional rhythm, was not associated with a lower CHQ-p. A multivariate model for CHQ-p score (n 5 324) using age and rate and rhythm variables demonstrated that resting heart rate (8.1point increase in CHQ-p score per 10 beats/min decrease at rest; P 5 .02) and peak heart rate (7.0-point increase in CHQ-p score per 10 beats/min increase during exercise; P 5 .01) were both independent predictors of CHQ-p. However, these variables accounted for only 4% of the variation in CHQ-p scores. Age, predominant rhythm, a history of atrial tachycardia, the presence of a pacemaker, and the change CHD from resting to peak heart rate were not independently associated with CHQ-p after accounting for resting and peak heart rate.
Associations with CHQ-ps Score None of the heart rate and rhythm variables were associated with CHQ-ps.
Discussion
This study provided a unique opportunity to analyze the associations of heart rate and rhythm with functional outcome in a large group of patients who had undergone the Fontan operation at 7 centers during a relatively uniform surgical era. The study offers new insight into the potential impact of these factors on the daily lives of Fontan patients. The specific new findings in this study are as follows: (1) resting heart rate as a continuous measure was inversely related to functional outcome measured by VAT and CHQ-p; (2) bradycardia (resting heart rate , fifth percentile for age) was not related to poor functional outcome; and (3) although lower than normal, peak heart rate during exercise was positively correlated with both VAT and CHQ-p. Additionally, this large sample, with its well-defined criteria for heart rate and rhythm abnormalities, provides a more accurate description of the prevalence of rate and rhythm abnormalities in patients who have undergone the Fontan procedure than has been previously available.
Heart Rate and Functional Outcome
The most intriguing finding in this study is that, independent of age, lower resting heart rate was not associated with wors-ened functional outcome. Since heart rate normally falls with age and outcome usually worsens with age, the relationship between resting heart rate and outcome should be even stronger if age-adjusted heart rates were available for use or could be accurately derived from existing data. Further, despite a large number of patients with bradycardia, defined as a resting heart rate less than the fifth percentile for age, bradycardia was not associated with decreased functional status. On the surface, this finding appears to be at odds with previous studies that have associated sinus node dysfunction with lower physical performance. Sinus node dysfunction has often been broadly defined as various combinations of the following: nonsinus rhythm on resting ECG, low resting heart rate, low peak heart rate response to exercise, or long pauses. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 15, 16, 23, 24 However, these prior studies have typically not separately analyzed the individual components of sinus node dysfunction, perhaps accounting for the differences with the findings in the present study. One possible explanation for the association between resting heart rate and functional outcome is that a high resting heart rate is an indicator of a poor functional state, perhaps resulting from low cardiac output and reflex sympathetic stimulation. Conversely, we speculate that a low resting heart rate may confer mechanical advantages to the Fontan ventricle. This may be related to longer diastolic filling times supporting the preload dependency of the Fontan circulation or to improvement in load-independent diastolic mechanics. Of note, very few patients had a resting heart rate above the 95th percentile for age. The data in this study do not address whether a low resting heart rate is part of a compensatory mechanism; however, previous authors have proposed that resting bradycardia in Fontan patients may be more likely to be the result of surgical or functional autonomic derangements, with selective reduction of cardiac sympathetic activation rather than sinus node dysfunction. 25 Any link between autonomic function and the association between higher CHQ-p score and lower heart rate will need to be substantiated in further studies. The role of peak heart rate in these patients may be more complex. It is clear that the population had an abnormal heart rate response to exercise, with 73% of subjects having an abnormally low chronotropic index. The chronotropic index may be a better representation of the expected peak heart rate response to exercise than the formula (peak heart rate 5 220 2 age [years]). 22 It is less clear whether the abnormal chronotropy is due to intrinsic sinus node dysfunction, autonomic derangements, or other mechanisms. Regardless of the etiology, a higher peak heart rate was associated with a higher VAT and a higher CHQ-p. Although this relationship was found to be weak in this group of Fontan patients, its existence is no different from that in patients with normal hearts, 26 in whom increasing heart rate is the most important mechanism for augmenting cardiac output during exercise.
Although other studies have demonstrated that pacing is indicated in Fontan patients with symptomatic bradycardia, 1, 3, 4 the clinical message from this study might be that good functional outcomes in patients with low resting heart rates suggests that placement of a pacemaker for asymptomatic bradycardia might not improve clinical status and may warrant very careful reconsideration. Inasmuch as a higher peak heart rate was also correlated with better functional outcome, failure to increase heart rate during exercise may be a better indicator of pacemaker necessity, but this needs to be evaluated in a prospective manner.
Heart Rate and Rhythm Abnormalities
Despite the more recent surgical era represented in the present study, the high incidence of heart rate and rhythm abnormalities in this Fontan population is consistent with that reported by previous authors. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In the present study, 27% of patients had resting heart rates below the fifth percentile for age, 31% had a nonsinus rhythm on resting ECG, and 41% had a peak heart rate less than 75% of predicted. Previous studies defined sinus node dysfunction as having any one of these abnormalities, 1-3 with a prevalence of up to 44% in select series. 4 Fishberger and associates 7 reported that 9.2% of Fontan patients had a pacemaker after a mean follow-up of 6 years, similar to the 13% prevalence during a followup of about 8.5 years in this study. Interestingly, the incidence of atrial tachycardia in the present study was lower than reported in prior studies despite a longer follow-up period (9.6% at 8.5 years compared with 16% to 17% at 5 years). 1, 5 Thus the impact of the more recent era may have been greater on the development of atrial tachycardia than on other heart rate and rhythm abnormalities.
Limitations
Despite the important findings presented here, this study has several limitations. First, since the study was observational, causality cannot be inferred from the associations identified. Second, although this study suggests that lower resting and higher peak heart rates may be beneficial in Fontan patients, these variables accounted for only 8% of the variance in CHQ-p, indicating that other factors may be more important in determining CHQ-p than heart rate. Third, the associations found between heart rate and CHQ-p or VAT arose from a subsample of the study cohort, which excluded patients who were paced and those receiving antiarrhythmic medication. Inasmuch as the study design did not allow for the reprogramming of pacemakers so that underlying rhythm could be manifest when assessing heart rate, it is unknown whether the relationships between underlying heart rate and CHQ-p or VAT would have been different in those patients with a pacemaker. However, despite exclusion of paced patients in the heart rate analysis, a large number of patients without a pacemaker had bradycardia and were included in the analysis, indicating that the results are reasonably applicable to most Fontan patients. It is possible that the patients with pacemakers may have had more profound bradycardia than the bradycardic patients without pacemakers. Thus excluding paced patients does not necessarily negate the relationship between resting heart rate and outcome for even the paced patients. Fourth, there was not a core laboratory for the ECG or exercise testing interpretation, so that institutional variability could have influenced the results. Fifth, a definition of atrial tachycardia based on chart review, study ECG, or exercise test may have underestimated the incidence of this problem compared with methods such as 24-hour ECG monitoring and electrophysiology study. Finally, associations with VAT have to be interpreted cautiously inasmuch as only 311 patients had valid VATs reported. For subjects who underwent exercise testing, those with a VAT measurement had better physical functioning on CHQ than those without a VAT measurement. In general, the analyses of VAT as an outcome measure for Fontan subjects are based on an older and possibly somewhat healthier cohort than the other findings. Inability to reach VAT may be an important determinant of functional outcome by itself.
Conclusions
In pediatric patients (6-18 years) after the Fontan procedure, a lower resting heart rate and a higher peak heart rate during exercise are each independently associated with improved physical functional outcome as measured by the physical component of the CHQ and the VAT. However, these correlations are weak, suggesting that other, nonrhythm and nonrate, factors may have a greater impact on the functional outcome of pediatric patients undergoing the Fontan operation.
